News & events
Q-linea publish the Annual report for 2025
Q-linea announces FDA clearance of expanded ASTar blood testing menu
Q-linea AB (publ) (OMX: QLINEA) today announces the company has received 510(k) clearance from the US FDA for its...
Read more >
Q-linea announces shipment of two ASTar® instruments to Saudi Arabia
Today Q-linea AB (publ) (OMX: QLINEA) announces two ASTar units will be shipped to hospitals in Saudi Arabia. Local...
Read more >
The nomination committee's proposals to Q-linea’s annual general meeting 2026
The nomination committee of Q-linea AB (publ) (Nasdaq Stockholm: QLINEA) has submitted its proposals to Q-linea´s annual general meeting...
Read more >
Year-end report 1 January – 31 December 2025
A solid foundation laid for a successful 2026The quarter October – December 2025• Net sales amounted to SEK 2.9 (0.2)...
Read more >
Load more